The role of BHLHE40 in clinical features and prognosis value of PDAC by comprehensive analysis and in vitro validation

Pancreatic ductal adenocarcinoma (PDAC) is the leading cause of cancer-related mortality, primarily due to the abundance of cancer-associated fibroblasts (CAFs), depleted effector T cells, and increased tumor cell stemness; hence, there is an urgent need for efficient biomarkers with prognostic and...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Chao Liu, Jiang Du, Jianwei Zheng, Ruizhe Zhang, Jialin Zhu, Bofan Xing, Lin Dong, Qianqian Zhou, Xiaofeng Yao, Song Gao, Yu Wang, Yu Ren, Xuan Zhou
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2023-06-01
Reeks:	Frontiers in Oncology
Onderwerpen:	BHLHE40 PDAC prognosis risk model tumor microenvironment
Online toegang:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1151321/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!